Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy
Yue Li, Zekun Du, Yuan Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 14
Monitoring ROS Responsive Fe3O4‐based Nanoparticle Mediated Ferroptosis and Immunotherapy via 129Xe MRI
Lei Zhang, Maosong Qiu, Ruifang Wang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 22
Closed Access | Times Cited: 14
Ti3C2Tx MXene quantum dots coated hollow manganese dioxide nanoparticles for tumor combination therapy and magnetic resonance imaging
Linwei Li, Zihan Xing, Tao Liao, et al.
Materials Today Chemistry (2024) Vol. 39, pp. 102171-102171
Closed Access | Times Cited: 11
Nanomedicine in Immunotherapy for Non‐Small Cell Lung Cancer: Applications and Perspectives
Shuangsi Liao, Xiaoling Li, You Lü, et al.
Small Methods (2025)
Open Access | Times Cited: 1
Traditional Chinese medicine in lung cancer treatment
Zhichao Xi, Rongchen Dai, Yufei Ze, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Ultrasmall Enzyodynamic PANoptosis Nano‐Inducers for Ultrasound‐Amplified Hepatocellular Carcinoma Therapy and Lung Metastasis Inhibition
Wuyang Wei, Hai Wang, Ren Chunrong, et al.
Advanced Materials (2024) Vol. 36, Iss. 45
Closed Access | Times Cited: 7
Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Materials Today Bio (2024) Vol. 26, pp. 101029-101029
Open Access | Times Cited: 6
Biomimetic nanosystems harnessing NIR-II photothermal effect and hypoxia-responsive prodrug for self-amplifying and synergistic tumor treatment
Lu Wang, Tianjiao Wang, Yushi Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102395-102395
Closed Access | Times Cited: 5
Identification of Promising Lung Cancer Drug Targets from Human Plasma Proteins: Mendelian Randomization,Single-Cell Rna Sequencing Analysis
Weijie Yu, Xiaodong Shao, Zhou-lin Miao
(2025)
Closed Access
An Integrated Virtual Screening Platform to Identify Potent Co‐Assembled Nanodrugs for Cancer Treatment
Bo Fang, Fei Pan, Tianyu Shan, et al.
Advanced Materials (2025)
Closed Access
Graphene oxide–chloroquine conjugate induces DNA damage in A549 lung cancer cells through autophagy modulation
Brahamdutt Arya, Sandeep Mittal, Prachi Joshi, et al.
Beilstein Journal of Nanotechnology (2025) Vol. 16, pp. 316-332
Open Access
Translational Selenium Nanoparticles Promotes Clinical Non‐small‐cell Lung Cancer Chemotherapy via Activating Selenoprotein‐driven Immune Manipulation
Yanzi Yu, Bin Xie, Jinlin Wang, et al.
Advanced Materials (2025)
Closed Access
YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway
Hongmei Zheng, Yaoxiang Tang, Hongjing Zang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Recent progress in nanomaterials for bacteria-related tumor therapy
Fuping Zhang, Shuyu Wang, Shuo Yang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 8, pp. 1965-1980
Closed Access | Times Cited: 4
Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer
Wenjuan Li, Shanhe Li, Minghui Zhu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17243-17258
Closed Access | Times Cited: 4
A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: a universal model for multifunctional lung cancer therapy
Zhonglei Wang, Wenjing Xu, Shizeng Lei, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 250, pp. 114557-114557
Closed Access
All-In-One Gadolinium–Doxorubicin Nanoassemblies for Spatial Delivery and Chemoresistance Reversal in Tumor Microenvironments
Guanyu Ruan, Li-Xiang Ye, Jianxi Ke, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Current and future therapies for small cell lung carcinoma
Xiaoqian Zhai, Zhengkun Zhang, Yuxin Chen, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Advancements in the Application of the Intersection of Medicine and Engineering in Cancer Research
Haitao Chen, Guan-Meng Zhang, Yuping Qian, et al.
(2025)
Open Access
A Cyanine Dye for Highly Specific Recognition of Parallel G-Quadruplex Topology and Its Application in Clinical RNA Detection for Cancer Diagnosis
Hongxia Sun, Ranran Sun, Dawei Yang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 32, pp. 22736-22746
Closed Access | Times Cited: 2
Novel Tris-bipyridine Based Ru(II) Complexes as Type-I/-II Photosensitizers for Antitumor Photodynamic Therapy Through Ferroptosis and Immunogenic Cell Death
Hongwei Zheng, K. Wang, Dongliang Ji, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116909-116909
Closed Access | Times Cited: 2
Nanobiotechnology boosts ferroptosis: opportunities and challenges
Shiqi Han, Jianhua Zou, Fan Xiao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Sweet MOFs: Exploring the Potential and Restraints of Integrating Carbohydrates with Metal-Organic Frameworks for Biomedical Applications
Alessio Zuliani, Víctor Ramos, Alberto Escudero, et al.
Nanoscale Horizons (2024)
Open Access | Times Cited: 2
Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 2
Progress in translating bioinorganic nanoplatform discoveries into clinical lung cancer care: Overcoming limitations, targeted drug delivery and imaging
Xuru Jin, Golnaz Heidari, Shefa Mirani Nezhad, et al.
Alexandria Engineering Journal (2024) Vol. 99, pp. 271-281
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top